JP2018518511A5 - - Google Patents

Download PDF

Info

Publication number
JP2018518511A5
JP2018518511A5 JP2017566839A JP2017566839A JP2018518511A5 JP 2018518511 A5 JP2018518511 A5 JP 2018518511A5 JP 2017566839 A JP2017566839 A JP 2017566839A JP 2017566839 A JP2017566839 A JP 2017566839A JP 2018518511 A5 JP2018518511 A5 JP 2018518511A5
Authority
JP
Japan
Prior art keywords
composition
subject
administration
immune
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017566839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518511A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/064613 external-priority patent/WO2016207314A2/en
Publication of JP2018518511A publication Critical patent/JP2018518511A/ja
Publication of JP2018518511A5 publication Critical patent/JP2018518511A5/ja
Pending legal-status Critical Current

Links

JP2017566839A 2015-06-26 2016-06-23 細胞質dna監視分子の調節方法 Pending JP2018518511A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562185230P 2015-06-26 2015-06-26
US62/185,230 2015-06-26
PCT/EP2016/064613 WO2016207314A2 (en) 2015-06-26 2016-06-23 Methods of modulating cytosolic dna surveillance molecules

Publications (2)

Publication Number Publication Date
JP2018518511A JP2018518511A (ja) 2018-07-12
JP2018518511A5 true JP2018518511A5 (https=) 2019-07-18

Family

ID=56235815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566839A Pending JP2018518511A (ja) 2015-06-26 2016-06-23 細胞質dna監視分子の調節方法

Country Status (22)

Country Link
US (1) US20190233825A1 (https=)
EP (1) EP3313376A2 (https=)
JP (1) JP2018518511A (https=)
KR (1) KR20180021874A (https=)
CN (1) CN108472255A (https=)
AR (1) AR105160A1 (https=)
AU (1) AU2016282879A1 (https=)
BR (1) BR112017028121A2 (https=)
CA (1) CA2990526A1 (https=)
CL (1) CL2017003373A1 (https=)
CR (1) CR20180003A (https=)
DO (1) DOP2017000313A (https=)
HK (1) HK1256128A1 (https=)
IL (1) IL256264A (https=)
MX (1) MX2017017141A (https=)
PE (1) PE20181208A1 (https=)
PH (1) PH12017502413A1 (https=)
RU (1) RU2018102915A (https=)
SG (1) SG10201913395VA (https=)
TW (1) TW201710509A (https=)
UY (1) UY36756A (https=)
WO (1) WO2016207314A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
CN109689095B (zh) 2016-07-26 2023-10-03 拜耳动物保健有限责任公司 牛物种中增加的生育力
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US155950A (en) * 1874-10-13 Improvement in hand-saws
ATE509102T1 (de) * 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
AU7690898A (en) * 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
CA2423093C (en) * 2000-09-25 2013-09-17 Valentis, Inc. Improved system for regulation of transgene expression
AU2002953015A0 (en) * 2002-12-02 2002-12-12 Women's And Children's Hospital Modified lacz gene
WO2005033265A2 (en) * 2003-04-25 2005-04-14 Epimmune Inc. Optimized multi-epitope constructs and uses thereof
TW200505425A (en) * 2003-05-29 2005-02-16 Schering Plough Ltd Compositions and method for treating infection in cattle and swine
JP2008511545A (ja) * 2004-08-13 2008-04-17 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 抗生物質耐性欠失dnaワクチン
US8906664B2 (en) * 2004-08-13 2014-12-09 The Trustees Of The University Of Pennsylvania Methods for constructing antibiotic resistance free vaccines
BRPI1010803A2 (pt) * 2009-05-14 2018-06-12 Bayer Animal Health Gmbh "resposta imune aumentada na espécie aviária"
UY33821A (es) * 2010-12-22 2012-07-31 Bayer Animal Health Gmbh Respuesta inmune potenciada en la especie bovina
US9359602B2 (en) * 2011-05-26 2016-06-07 Intervet Inc. Immunostimulatory oligodeoxynucleotides
AR091569A1 (es) * 2012-06-28 2015-02-11 Intervet Int Bv Receptores de tipo toll
EP3110940A1 (en) * 2014-02-28 2017-01-04 Bayer Animal Health GmbH Immunostimulatory plasmids

Similar Documents

Publication Publication Date Title
US12161711B2 (en) Lassa virus vaccine
US11771653B2 (en) Lipid nanoparticles for delivering mRNA vaccines
JP7523897B2 (ja) 呼吸器合胞体ウイルス(rsv)ワクチン
JP2017512202A5 (https=)
US20210401971A1 (en) Mers coronavirus vaccine
JP4782675B2 (ja) ワクチン接種用スフィンゴイドポリアルキルアミン抱合体
JP4294584B2 (ja) 核酸ワクチン接種の免疫応答を高めるための方法
RU2013133730A (ru) Повышение иммунного отклика у видов крупного рогатого скота
RU2016138321A (ru) Иммуностимулирующие плазмиды
US12331078B2 (en) Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same
JP2018518511A5 (https=)
EP4153224A1 (en) Coronavirus antigen compositions and their uses
CN116406299A (zh) 用于递送mRNA疫苗的脂质纳米颗粒
US20230136960A1 (en) Novel MRNA-Based COVID-19 Multi-Valent Vaccine and Methods of Scaled Production of the Same
TW201427686A (zh) 改良之疫苗組成物及使用方法
RU2018102915A (ru) Способы модуляции контрольных молекул цитозольной днк
CN121419787A (zh) 多价流感mRNA疫苗
AR105568A1 (es) Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina
AU2017386682A1 (en) Influenza vaccines
US20220175909A1 (en) Influenza vaccine composition based on novel nucleic acid
JP2023550667A (ja) 免疫刺激性組成物
WO2024211625A1 (en) Hbv gene editing
JP2026500282A (ja) インフルエンザウイルス様粒子をコードするmRNA
WO2023218420A1 (en) Mrna compositions for inducing latent hiv-1 reversal
WO2026085256A1 (en) Lipid nanoparticles and methods of use